CAPR News and Press, Capricor Therapeutics Inc. From 10/04/23

2023-10-04 16:06:31 ET An estimated 250,000-500,000 people experience a %SpinalCordInjury (SCI) annually, with roughly 17,000 new cases in the US and 27,000 in Europe each year, leaving many of those people permanently confined to a wheelchair. What if there were a way to repair the dam...

Toronto, Ontario--(Newsfile Corp. - October 4, 2023) - Caprock Mining Corp. (CSE: CAPR) (" Caprock " or the " Company ") is pleased to announce that it has filed on SEDAR+ the National Instrument 43-101 ("NI 43-101") Technical Report (the " Technical Report ") for its recently optioned Ackley Lit...

2023-09-29 09:36:50 ET More on Capricor Capricor: Q4 2023 Interim Analysis For DMD Treatment Makes This A Must Watch Capricor Therapeutics, Inc. (CAPR) Q2 2023 Earnings Call Transcript Capricor Therapeutics slumps 25%, prices $23M equity Seeking Alpha’...

2023-09-29 09:06:05 ET More on Capricor Therapeutics Capricor: Q4 2023 Interim Analysis For DMD Treatment Makes This A Must Watch Seeking Alpha’s Quant Rating on Capricor Therapeutics Historical earnings data for Capricor Therapeutics For further detai...

SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, today announced that it has ...

-FDA Feedback on the Proposed Key Clinical and Regulatory Requirements Confirms CAP-1002’s Path Towards a Biologics License Application (BLA)- -Company On Track to Complete HOPE-3 Enrollment and Report Outcome from Interim Analysis in Q4 2023- -Conference Call and Webcast T...

Toronto, Ontario--(Newsfile Corp. - September 20, 2023) - Caprock Mining Corp. (CSE: CAPR) (" Caprock " or the " Company ") is pleased to announce high-grade lithium assay results from samples obtained during a recently concluded prospecting and sampling program on the eastern-most claim block (t...

Toronto, Ontario--(Newsfile Corp. - September 11, 2023) - Caprock Mining Corp. (CSE: CAPR) (" Caprock " or the " Company ") is pleased to announce that its technical team has discovered the presence of zinnwaldite, an extraordinary lithium-bearing mineral, during a recently concluded prospecting ...

SAN DIEGO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, today announced that the...

2023-08-16 09:31:41 ET Summary There is an ongoing phase 3 study, known as HOPE-3, deploying the use of CAP-1002 for the treatment of patients with Duchenne Muscular Dystrophy; Interim analysis expected Q4 of 2023. A Type-B FDA meeting was held between the company and the FDA; Min...